Top Insights from 2025 (So Far)
Explore the Trends, Challenges, and Opportunities Shaping Pharma’s Commercial Future
Throughout 2025, Evaluate leverages its gold-standard forecast data to unpack the biggest trends, most dynamic therapy areas, and toughest commercial challenges facing the pharma industry. From long-range market outlooks to strategic deal-making and the evolving role of competitive intelligence, our reports offer the clarity and context you need to stay ahead.
Here are some of the standout reports from our 2025 archive:
eBook / Report
1.
2025 World preview: Pharma Growth Steady Amid Turbulent Seas and Rising China
eBook / Report
2.
The Methodology Trilogy: How to Forecast like a King
Report
3.
2024 Deal-making Roundup
eBook / Report
4.
Optimizing the Strategic Value of Competitive Intelligence
eBook / Report
5.
Going Solo: Biotech Commercialization
eBook / Report
6.
2025 Preview: What Does the Year Ahead Hold for Pharma?
Visit our Resource Centre for the full library of blogs, reports, webinars and more.
Content hubs
Big questions on critical topics? Find our key insight and analysis in our content hubs.
HOW WE HELP
Connected data gives you a clearer picture.
Evaluate gives you the understanding and time you need to drive better decisions.
Market Opportunity Sizing
Identify the market that offers the greatest potential for your business so you can confidently prioritise assets and allocate resources.
Commercial Opportunity Assessment
Develop a robust view of potential partners and licensing opportunities to boost your pipeline and amplify your commercial success.
Competitive Landscape Analysis
Build a clear analysis of the evolving landscape – market dynamics, emerging trends and key players – and make strategic moves that strengthen your position.
Company Profiling
Monitor key companies so you can track potential partners and competitors and find opportunities in a constantly changing environment.
Asset Screening
Obtain a clear and unbiased assessment of asset value to drive licensing decisions and ensure you invest in assets with the highest potential for success.
Deal Benchmarking
Bring confidence to your allocation strategy with timely external benchmarking data across the R&D landscape.
